Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,053,000 | 1,979,000 | 2,127,000 | 2,200,000 | 2,215,000 |
| Income taxes - deferred | -194,000 | -745,000 | -34,000 | -91,000 | -28,000 |
| Accounts receivable | -785,000 | -749,000 | 590,000 | -296,000 | -866,000 |
| Accounts payable and accrued liabilities | -258,000 | 174,000 | 1,146,000 | 72,000 | 236,000 |
| Other Working Capital | -1,275,000 | -1,084,000 | 1,708,000 | -990,000 | -956,000 |
| Other Operating Activity | 5,367,000 | 5,500,000 | 2,398,000 | 3,995,000 | 4,276,000 |
| Operating Cash Flow | $4,908,000 | $5,075,000 | $7,935,000 | $4,890,000 | $4,877,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -162,000 | -187,000 | -217,000 | -195,000 | -188,000 |
| Net Acquisitions | -185,000 | -1,065,000 | -492,000 | -147,000 | -198,000 |
| Purchase Of Investment | -1,406,000 | -46,000 | -17,000 | -40,000 | -16,000 |
| Sale Of Investment | 8,000 | 10,000 | 23,000 | 54,000 | 11,000 |
| Other Investing Activity | 154,000 | 143,000 | 88,000 | 86,000 | 49,000 |
| Investing Cash Flow | $-1,591,000 | $-1,145,000 | $-615,000 | $-242,000 | $-342,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000,000 | 0 | 1,000,000 | N/A | N/A |
| Debt Repayment | -4,879,000 | -3,752,000 | -2,201,000 | N/A | N/A |
| Common Stock Repurchased | -1,470,000 | -131,000 | -6,000 | -10,000 | -787,000 |
| Dividend Paid | -2,526,000 | -2,314,000 | -2,315,000 | -2,310,000 | -2,322,000 |
| Other Financing Activity | -97,000 | -141,000 | -121,000 | -3,564,000 | -65,000 |
| Financing Cash Flow | $-6,972,000 | $-6,338,000 | $-3,643,000 | $-5,884,000 | $-3,174,000 |
| Exchange Rate Effect | 7,000 | -28,000 | -41,000 | 27,000 | -55,000 |
| Beginning Cash Position | 9,746,000 | 12,182,000 | 8,546,000 | 9,755,000 | 8,449,000 |
| End Cash Position | 6,098,000 | 9,746,000 | 12,182,000 | 8,546,000 | 9,755,000 |
| Net Cash Flow | $-3,655,000 | $-2,408,000 | $3,677,000 | $-1,236,000 | $1,361,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,908,000 | 5,075,000 | 7,935,000 | 4,890,000 | 4,877,000 |
| Capital Expenditure | -162,000 | -187,000 | -217,000 | -195,000 | -188,000 |
| Free Cash Flow | 4,746,000 | 4,888,000 | 7,718,000 | 4,695,000 | 4,689,000 |